Health Care & Life Sciences » Pharmaceuticals | Hubei Jumpcan Pharmaceutical Co. Ltd.

Hubei Jumpcan Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,406
2,935
3,704
4,588
5,534
7,076
Cost of Goods Sold (COGS) incl. D&A
395
496
636
734
899
1,170
Gross Income
2,011
2,439
3,068
3,853
4,634
5,906
SG&A Expense
1,576
1,873
2,316
2,808
3,287
4,040
EBIT
425
551
739
1,073
1,346
1,867
Non Operating Income/Expense
-
1
3
3
73
82
Interest Expense
-
14
4
2
6
35
Pretax Income
463
605
800
1,088
1,436
1,976
Income Tax
62
85
116
154
212
289
Equity in Affiliates
-
2
-
-
-
1
Consolidated Net Income
403
519
683
934
1,224
1,688
Net Income
403
519
687
934
1,223
1,688
Net Income After Extraordinaries
403
519
687
934
1,223
1,688
Net Income Available to Common
403
519
687
934
1,223
1,688
EPS (Basic)
0.66
0.67
0.88
1.17
1.51
2.08
Basic Shares Outstanding
611
775
781
798
810
811
EPS (Diluted)
0.66
0.67
0.88
1.17
1.51
2.07
Diluted Shares Outstanding
611
775
781
798
810
815
EBITDA
492
637
851
1,189
1,496
2,045
Other Operating Expense
10
15
13
28
1
1
Non-Operating Interest Income
1
18
17
18
23
54
Minority Interest Expense
-
-
-
-
3
-

About Hubei Jumpcan Pharmaceutical Co.

View Profile
Address
Baota Bay
Taizhou Jiangsu 225441
China
Employees -
Website -
Updated 07/08/2019
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the drug research and development, production, and sale. Its product covers pediatrics, breathing, and digestion field. Its product focuses on anti-inflammatory oral solution, enteric-coated capsules, and children fever particles.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.